A Whole-food, Plant-Based Nutrition Intervention in Women With Metastatic Breast Cancer
NCT03045289 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2022-07-13
Summary
This research will examine the feasibility of conducting a strict whole-food, plant-based dietary intervention in women with stable metastatic breast cancer currently undergoing conventional treatments. In addition, this research will provide preliminary data on dietary intakes and the effect of plant-based nutrition on numerous outcomes reflecting cancer prognosis and overall health using advanced imaging, various blood biomarkers linked to cancer progression, and numerous symptom questionnaires.
Conditions
- Metastatic Breast Cancer
- Breast Cancer Stage IV
Interventions
- BEHAVIORAL
-
Plant-Based Diet
Women will be provided with 3 meals daily, delivered to their home, for 8 weeks, along with a multivitamin, and will attend weekly office visits.
Sponsors & Collaborators
- collaborator OTHER
-
University of Rochester
lead OTHER
Principal Investigators
-
Thomas M Campbell, MD · University of Rochester
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-07-05
- Primary Completion
- 2022-07-01
- Completion
- 2022-07-01
Countries
- United States
Study Locations
More Related Trials
-
Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma
NCT00225056 ·Status: TERMINATED ·Phase: PHASE2
-
Capecitabine in Women With Operable Breast Cancer
NCT00148720 ·Status: TERMINATED ·Phase: PHASE2
-
An All-Oral Combination of Capecitabine and Cyclophosphamide in Patients With Metastatic Breast Cancer (MBC)
NCT00589901 ·Status: UNKNOWN ·Phase: PHASE2
-
Eradication of Malignant Carcinoma in the Breast Tissue
NCT02286778 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer
NCT00316199 ·Status: COMPLETED ·Phase: PHASE2
-
Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer
NCT05090358 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response
NCT00483223 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Immunological Effects of a Combined Treatment With Radiation and Cyclophosphamide in Metastasized Breast Cancer Patients
NCT02441270 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer
NCT00322517 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer
NCT03775525 ·Status: UNKNOWN ·Phase: PHASE1
-
Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer Patients
NCT00317603 ·Status: COMPLETED ·Phase: PHASE1
-
Study for Using Radiosurgery on Limited Metastases of Breast Cancer
NCT00167414 ·Status: COMPLETED ·Phase: NA
-
BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast Cancer
NCT03603197 ·Status: COMPLETED ·Phase: PHASE2
-
Herbal Therapy in Treating Women With Metastatic Breast Cancer
NCT00028977 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
NCT06536881 ·Status: RECRUITING ·Phase: NA
-
Intensive Combo Chemo With Autologous BM Rescue for Metastatic Breast Cancer
NCT00584766 ·Status: COMPLETED ·Phase: PHASE2
-
Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer
NCT00616967 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer
NCT00347438 ·Status: TERMINATED ·Phase: PHASE2
-
Management of Metastatic Breast Cancer in Frail Patients
NCT00005614 ·Status: WITHDRAWN ·Phase: PHASE2
-
Capecitabine in Treating Patients With Metastatic Breast Cancer
NCT00274768 ·Status: COMPLETED ·Phase: PHASE2
-
Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer
NCT01281163 ·Status: TERMINATED ·Phase: PHASE1
-
Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast Cancer
NCT01924078 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation
NCT02860585 ·Status: COMPLETED
-
A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer
NCT00907959 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
NCT00087620 ·Status: TERMINATED ·Phase: PHASE4